Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-010638
Filing Date
2023-02-17
Accepted
2023-02-17 16:30:52
Documents
1
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3959
  Complete submission text file 0001209191-23-010638.txt   5562
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Issuer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address MOLECULAR INSIGHT PHARMCEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
LaFrance Norman D. (Reporting) CIK: 0001397768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34375 | Film No.: 23643120